Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study

INTRODUCTION: Trastuzumab in combination with platinum-based chemotherapy is the standard first-line regimen in HER2-positive advanced gastric cancer. However, there are very few data concerning efficacy of continuing trastuzumab beyond first-line progression. METHODS: This retrospective multicenter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Palle, Juliette, Tougeron, David, Pozet, Astrid, Soularue, Emilie, Artru, Pascal, Leroy, Florence, Dubreuil, Olivier, Sarabi, Matthieu, Williet, Nicolas, Manfredi, Sylvain, Martin-Babau, Jerome, Rebischung, Christine, Abdelghani, Meher Ben, Evesque, Ludovic, Dreanic, Johann, Hautefeuille, Vincent, Louafi, Samy, Sefrioui, David, Savinelli, Francesco, Mabro, May, Rousseau, Benoit, Lecaille, Cédric, Bouché, Olivier, Louvet, Christophe, Lecomte, Thierry, Bonnetain, Franck, Taieb, Julien, Zaanan, Aziz
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2017
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731882/
https://ncbi.nlm.nih.gov/pubmed/29254172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20711
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge